Skip to content

Disc Medicine IRON Accounts Payable

Accounts Payable at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.23B+5.8%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$489.3M+10.0%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$13.75M+0.2%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$12.29M+59.6%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$12.91M-16.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$29.06M+5.6%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's accounts payable?
Disc Medicine (IRON) reported accounts payable of $11.76M in Q1 2026.
How has Disc Medicine's accounts payable changed year-over-year?
Disc Medicine's accounts payable increased by 75.4% year-over-year, from $6.7M to $11.76M.
What is the long-term trend for Disc Medicine's accounts payable?
Over 4 years (2021 to 2025), Disc Medicine's accounts payable has grown at a 36.1% compound annual growth rate (CAGR), from $8.55M to $29.34M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.